BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 12671996)

  • 1. Growth arrest of PC12 cells by nerve growth factor is dependent on the phosphatidylinositol 3-kinase/Akt pathway via p75 neurotrophin receptor.
    Ito H; Nomoto H; Furukawa S
    J Neurosci Res; 2003 Apr; 72(2):211-7. PubMed ID: 12671996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of low-affinity p75 receptor in nerve growth factor-inducible growth arrest of PC12 cells.
    Ito H; Nomoto H; Furukawa S
    J Neurosci Res; 2002 Sep; 69(5):653-61. PubMed ID: 12210831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NGF-withdrawal induces apoptosis in pancreatic beta cells in vitro.
    Pierucci D; Cicconi S; Bonini P; Ferrelli F; Pastore D; Matteucci C; Marselli L; Marchetti P; Ris F; Halban P; Oberholzer J; Federici M; Cozzolino F; Lauro R; Borboni P; Marlier LN
    Diabetologia; 2001 Oct; 44(10):1281-95. PubMed ID: 11692177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p75 neurotrophin receptor is required for constitutive and NGF-induced survival signalling in PC12 cells and rat hippocampal neurones.
    Bui NT; König HG; Culmsee C; Bauerbach E; Poppe M; Krieglstein J; Prehn JH
    J Neurochem; 2002 May; 81(3):594-605. PubMed ID: 12065668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p75NTR-mediated signaling promotes the survival of myoblasts and influences muscle strength.
    Reddypalli S; Roll K; Lee HK; Lundell M; Barea-Rodriguez E; Wheeler EF
    J Cell Physiol; 2005 Sep; 204(3):819-29. PubMed ID: 15754321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel functional interactions between Trk kinase and p75 neurotrophin receptor in neuroblastoma cells.
    Lachyankar MB; Condon PJ; Daou MC; De AK; Levine JB; Obermeier A; Ross AH
    J Neurosci Res; 2003 Jan; 71(2):157-72. PubMed ID: 12503079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of PLC-gamma1 activity converts nerve growth factor from an anti-mitogenic to a mitogenic signal in CHO cells.
    Zapf-Colby A; Eichhorn J; Webster NJ; Olefsky JM
    Oncogene; 1999 Sep; 18(35):4908-19. PubMed ID: 10490825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The p75 neurotrophin receptor enhances TrkA signalling by binding to Shc and augmenting its phosphorylation.
    Epa WR; Markovska K; Barrett GL
    J Neurochem; 2004 Apr; 89(2):344-53. PubMed ID: 15056278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nerve growth factor survival signaling in cultured hippocampal neurons is mediated through TrkA and requires the common neurotrophin receptor P75.
    Culmsee C; Gerling N; Lehmann M; Nikolova-Karakashian M; Prehn JH; Mattson MP; Krieglstein J
    Neuroscience; 2002; 115(4):1089-108. PubMed ID: 12453482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pertussis toxin-sensitive Gi/o proteins are involved in nerve growth factor-induced pro-survival Akt signaling cascade in PC12 cells.
    Wu EH; Wong YH
    Cell Signal; 2005 Jul; 17(7):881-90. PubMed ID: 15763430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nerve growth factor-induced protein kinase C stimulation contributes to TrkA-dependent inhibition of p75 neurotrophin receptor sphingolipid signaling.
    Plo I; Bono F; Bezombes C; Alam A; Bruno A; Laurent G
    J Neurosci Res; 2004 Aug; 77(4):465-74. PubMed ID: 15264216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
    Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW
    Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TrkA as a life and death receptor: receptor dose as a mediator of function.
    Yan C; Liang Y; Nylander KD; Schor NF
    Cancer Res; 2002 Sep; 62(17):4867-75. PubMed ID: 12208732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
    Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T
    Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia activates a platelet-derived growth factor receptor/phosphatidylinositol 3-kinase/Akt pathway that results in glycogen synthase kinase-3 inactivation.
    Chen EY; Mazure NM; Cooper JA; Giaccia AJ
    Cancer Res; 2001 Mar; 61(6):2429-33. PubMed ID: 11289110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FKHRL1 and its homologs are new targets of nerve growth factor Trk receptor signaling.
    Zheng WH; Kar S; Quirion R
    J Neurochem; 2002 Mar; 80(6):1049-61. PubMed ID: 11953455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinction between differentiation, cell cycle, and apoptosis signals in PC12 cells by the nerve growth factor mutant delta9/13, which is selective for the p75 neurotrophin receptor.
    Hughes AL; Messineo-Jones D; Lad SP; Neet KE
    J Neurosci Res; 2001 Jan; 63(1):10-9. PubMed ID: 11169609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple acute effects on the membrane potential of PC12 cells produced by nerve growth factor (NGF).
    Shimazu K; Takeda K; Yu ZX; Jiang H; Liu XW; Nelson PG; Guroff G
    J Cell Physiol; 2005 Jun; 203(3):501-9. PubMed ID: 15729735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The p75NTR intracellular domain generated by neurotrophin-induced receptor cleavage potentiates Trk signaling.
    Ceni C; Kommaddi RP; Thomas R; Vereker E; Liu X; McPherson PS; Ritter B; Barker PA
    J Cell Sci; 2010 Jul; 123(Pt 13):2299-307. PubMed ID: 20530577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MKK7γ1 reverses nerve growth factor signals: proliferation and cell death instead of neuritogenesis and protection.
    Haeusgen W; Herdegen T; Waetzig V
    Cell Signal; 2011 Aug; 23(8):1281-90. PubMed ID: 21406225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.